Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissue Hydraulic Resistance and Subcutaneous Insulin Absorption in Insulin Infusion Sites
2022-003537-18Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of insulin aspart in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz. Primary endpoint: AUCinsulin. Started Dec 2022; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2022-003537-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003537-18.